SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    P. S. V. N. Sharma, Sreejayan Kongasseri, Samir Kumar Praharaj, Outcome of Mood Stabilizer Discontinuation in Bipolar Disorder After 5 Years of Euthymia, Journal of Clinical Psychopharmacology, 2014, 34, 4, 504

    CrossRef

  2. 2
    Jo Minay, Raymond Paul, Deirdre McGarvey, Gerard Savage, Mike Stevenson, Damian Fogarty, Ciaran Mulholland, Christopher Kelly, Lithium usage and renal function testing in a large UK community population; a case–control study, General Hospital Psychiatry, 2013, 35, 6, 631

    CrossRef

  3. 3
    Christine Vries, Annet Bergen, Eline J Regeer, Elsje Benthem, Ralph W Kupka, Marco PM Boks, The effectiveness of restarted lithium treatment after discontinuation: reviewing the evidence for discontinuation-induced refractoriness, Bipolar Disorders, 2013, 15, 6
  4. 4
    Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller, Siegfried Kasper, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder, The World Journal of Biological Psychiatry, 2013, 14, 3, 154

    CrossRef

  5. 5
    Michael Gitlin, Mark A Frye, Maintenance therapies in bipolar disorders, Bipolar Disorders, 2012, 14,
  6. 6
    Mats Adler, Lena Backlund, Gunnar Edman, Urban Ösby, Symptoms and treatment of bipolar patients in Sweden, International Journal of Psychiatry in Clinical Practice, 2012, 16, 3, 170

    CrossRef

  7. 7
    Lesley Berk, Karen T. Hallam, Francesc Colom, Eduard Vieta, Melissa Hasty, Craig Macneil, Michael Berk, Enhancing medication adherence in patients with bipolar disorder, Human Psychopharmacology: Clinical and Experimental, 2010, 25, 1
  8. 8
    Robert H. Howland, Potential Adverse Effects of Discontinuing Psychotropic Drugs, Journal of Psychosocial Nursing and Mental Health Services, 2010, 48, 8, 11

    CrossRef

  9. 9
    Toshihiko Yanagita, Toyoaki Maruta, Takayuki Nemoto, Yasuhito Uezono, Kiyotaka Matsuo, Shinya Satoh, Norie Yoshikawa, Tasuku Kanai, Hideyuki Kobayashi, Akihiko Wada, Chronic lithium treatment up-regulates cell surface NaV1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: Enhancement of Na+ influx, Ca2+ influx and catecholamine secretion after lithium withdrawal, Neuropharmacology, 2009, 57, 3, 311

    CrossRef

  10. 10
    Lena Backlund, Anna Ehnvall, Jerker Hetta, Göran Isacsson, Hans Ågren, Identifying predictors for good lithium response – A retrospective analysis of 100 patients with bipolar disorder using a life-charting method, European Psychiatry, 2009, 24, 3, 171

    CrossRef

  11. 11
    Etienne Marc Grandjean, Jean-Michel Aubry, Lithium: Updated Human Knowledge Using an Evidence-Based Approach, CNS Drugs, 2009, 23, 5, 397

    CrossRef

  12. 12
    SHELDON H. PRESKORN, Deconstructing a Medication Regimen, Journal of Psychiatric Practice, 2008, 14, 2, 114

    CrossRef

  13. 13
    Håkan Odeberg, Bruce Rodriguez-Silva, Pirjo Salander, Björn Mårtensson, Individualized Continuation Electroconvulsive Therapy and Medication as a Bridge to Relapse Prevention After an Index Course of Electroconvulsive Therapy in Severe Mood Disorders, The Journal of ECT, 2008, 24, 3, 183

    CrossRef

  14. 14
    Lars Søndergård, Ana Garcia Lopez, Per Kragh Andersen, Lars Vedel Kessing, Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide, Bipolar Disorders, 2008, 10, 1
  15. 15
    J. Rohayem, J.-F. Baylé, S. Richa, Prédicteurs de réponse prophylactique au lithium, L'Encéphale, 2008, 34, 4, 394

    CrossRef

  16. 16
    Matthew G Biel, Eric Peselow, Loretta Mulcare, Brady G Case, Ron Fieve, Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study, Bipolar Disorders, 2007, 9, 5
  17. 17
    Andrew J. Goudie, Jon C. Cole, Harry R. Sumnall, Olanzapine withdrawal/discontinuation-induced hyperthermia in rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007, 31, 7, 1500

    CrossRef

  18. You have free access to this content18
    Ross J Baldessarini, Leonardo Tondo, Paula Davis, Maurizio Pompili, Frederick K Goodwin, John Hennen, Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review, Bipolar Disorders, 2006, 8, 5p2
  19. 19
    J. Moncrieff, Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse, Acta Psychiatrica Scandinavica, 2006, 114, 1
  20. 20
    Marlene P. Freeman, Scott A. Freeman, Lithium: Clinical Considerations in Internal Medicine, The American Journal of Medicine, 2006, 119, 6, 478

    CrossRef

  21. 21
    JAMES C.-Y. CHOU, LYDIA FAZZIO, Maintenance Treatment of Bipolar Disorder: Applying Research to Clinical Practice, Journal of Psychiatric Practice, 2006, 12, 5, 283

    CrossRef

  22. 22
    Robert K. McNamara, Michelle Ostrander, William Abplanalp, Neil M. Richtand, Stephen C. Benoit, Debbie J. Clegg, Modulation of phosphoinositide–protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2006, 75, 4-5, 237

    CrossRef

  23. 23
    Ana Gonzalez-Pinto, Fernando Mosquera, Marta Alonso, Purificación López, Fernando Ramírez, Eduard Vieta, Ross J Baldessarini, Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment, Bipolar Disorders, 2006, 8, 5p2
  24. 24
    F Centorrino, J J Wurtman, K A Duca, V H Fellman, K V Fogarty, J M Berry, D M Guay, M Romeling, J Kidwell, S L Cincotta, R J Baldessarini, Weight loss in overweight patients maintained on atypical antipsychotic agents, International Journal of Obesity, 2006, 30, 6, 1011

    CrossRef

  25. 25
    Joanna Moncrieff, Why is it so difficult to stop psychiatric drug treatment?, Medical Hypotheses, 2006, 67, 3, 517

    CrossRef

  26. 26
    D Deshauer, D Fergusson, A Duffy, J Albuquerque, P Grof, Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect, Bipolar Disorders, 2005, 7, 4
  27. 27
    Luiz Dratcu, Dominiek Bamelis, Susan E. Libretto, Risperidone long-acting injection, a promising treatment for patients with bipolar disorder, Journal of Mental Health, 2005, 14, 5, 523

    CrossRef

  28. 28
    Moritz Mühlbacher, Christoph Egger, Marius Nickel, W. Hitzl, Christoph Stuppäck, Veränderungen der Verschreibungsgewohnheiten in der medikamentösen Behandlung der Bipolaren Erkrankung, Psychiatrie und Psychotherapie, 2005, 1, 2, 57

    CrossRef

  29. 29
    Vivienne Curtis, Women are not the same as men: specific clinical issues for female patients with bipolar disorder, Bipolar Disorders, 2005, 7,
  30. 30
    G. J. R. Mensink, C. J. Slooff, Novel antipsychotics in bipolar and schizoaffective mania, Acta Psychiatrica Scandinavica, 2004, 109, 6
  31. 31
    Daniel Z. Lieberman, Frederick K. Goodwin, Separate and concomitant use of lamotrigine, lithium, and divalproex in bipolar disorders, Current Psychiatry Reports, 2004, 6, 6, 459

    CrossRef

  32. 32
    Heinz Grunze, Siegfried Kasper, Guy Goodwin, Charles Bowden, Hans-ju¨rgen Mo¨ller, WFSBP Task Force on Treatment Guide, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment, World Journal of Biological Psychiatry, 2004, 5, 3, 120

    CrossRef

  33. 33
    Leonardo Tondo, G??ran Isacsson, Ross J Baldessarini, Suicidal Behaviour in Bipolar Disorder, CNS Drugs, 2003, 17, 7, 491

    CrossRef

  34. 34
    Mario Maj, The effect of lithium in bipolar disorder: a review of recent research evidence, Bipolar Disorders, 2003, 5, 3
  35. 35
    Bruno Müller-Oerlinghausen, Anne Berghöfer, Michael Bauer, Bipolar disorder, The Lancet, 2002, 359, 9302, 241

    CrossRef

  36. 36
    Adele C Viguera, Lee J Cohen, Leonardo Tondo, Ross J Baldessarini, Letter to the Editor of the Journal of Affective Disorders, Journal of Affective Disorders, 2002, 72, 1, 107

    CrossRef

  37. 37
    Ross J. Baldessarini, Treatment Research in Bipolar Disorder, CNS Drugs, 2002, 16, 11, 721

    CrossRef

  38. 38
    James Ko, Polypharmacy in Psychiatry, 2002,

    CrossRef

  39. 39
    S Nassir Ghaemi, On defining ‘mood stabilizer’, Bipolar Disorders, 2001, 3, 3
  40. 40
    R.S. El-Mallakh, M.E. Paskitti, The ketogenic diet may have mood-stabilizing properties, Medical Hypotheses, 2001, 57, 6, 724

    CrossRef

  41. 41
    Ross J. Baldessarini, Leonardo Tondo, John Hennen, Treating the Suicidal Patient with Bipolar Disorder, Annals of the New York Academy of Sciences, 2001, 932, 1
  42. 42
    R.J. Baldessarini, L. Tondo, International Encyclopedia of the Social & Behavioral Sciences, 2001,

    CrossRef

  43. 43
    Trevor Silverstone, Is Lithium Still the Maintenance Treatment of Choice for Bipolar Disorder?, CNS Drugs, 2000, 14, 2, 81

    CrossRef

  44. 44
    Samuel I. Miles, Psychopharmacology, Wiley Encyclopedia of Forensic Science,